Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcow-K2
- Development stage
- Unknown
- Lead developer
- Wellmed Pharma
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Calcow-K2 is a branded generic nutritional supplement marketed by Wellmed Pharma, an Indian pharmaceutical company. It is a finished-dose formulation typically composed of Calcium, Vitamin K2 (often as Menaquinone-7), and Vitamin D3 (Cholecalciferol). The product is designed to support bone health and mineral density. Calcium provides the essential structural component for bone formation, while Vitamin D3 enhances its intestinal absorption. Vitamin K2 plays a critical role in bone metabolism by activating osteocalcin, a protein required to bind calcium to the bone matrix, and activating matrix GLA protein to prevent calcium deposition in the vascular system. It is primarily used for the prevention and treatment of osteoporosis, osteopenia, and calcium or vitamin deficiencies.
- Brand names
- Calcow-K2Calcow-K-2Calcow-K 2
- Other names
- Calcium + Vitamin K2 + Vitamin D3 Wellmed Pharma
02
Targets
MGP (Matrix Gla protein)VDR (Vitamin D receptor)GGCX (Vitamin K-dependent gamma-glutamyl carboxylase)
Beyond the preview
Go deeper on Calcow-K2.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Calcow-K2.